Science
Mechanism of Action
This precision peptide, a 53-amino acid recombinant analog of human EGF, binds to specific epidermal growth factor receptors (EGFR) on keratinocytes upon topical application. This interaction is designed to initiate intracellular signaling pathways that stimulate cell growth, proliferation, differentiation, and overall tissue repair. It theoretically enhances collagen and elastin production, promoting skin elasticity and reducing the appearance of fine lines. Furthermore, it aims to boost fibroblast activity, increase hyaluronic acid synthesis, accelerate wound healing, reinforce the skin barrier, and mitigate inflammatory responses, thereby contributing to improved moisturization, reduced redness, and more even skin tone.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Given the substantial molecular weight of sh-Oligopeptide-1, its ability to penetrate an intact skin barrier for effective action in cosmetic formulations is highly debated, with the China National Drug Administration (CNDA) specifically citing this as a reason for its unsuitability as a cosmetic raw material. Furthermore, a 2023 review questions its fundamental bioactivity, suggesting that its inclusion in many cosmetic products may be largely symbolic rather than functionally effective, aligning with 'dusting' practices.
The Formula
Formulation
Stability
To preserve its biological activity, SILKWORM SH-OLIGOPEPTIDE-1 typically requires low-temperature storage, ideally between 2-8°C, or at -20°C for extended periods. While some advanced formulations claim room-temperature stability, it is susceptible to decomposition by microbial enzymes. Therefore, strict avoidance of microbial contamination is crucial. For optimal integration, it should be added as the final ingredient during formulation, ensuring the temperature remains below 45°C.
Conflicts
- Exposure to high temperatures (above 45°C) during formulation, which can degrade its activity.
- Microbial contamination, which can lead to enzymatic decomposition and loss of efficacy.
- Formulation for use on an intact skin barrier, as its large molecular weight is cited to significantly hinder absorption, potentially rendering it ineffective.
Safety
Safety Profile
While generally considered not carcinogenic due to EGF's mitogenic but non-mutagenic nature, caution is advised as EGF signaling is prevalent in various tumor cells; individuals at risk of skin cancer or with psoriasis should avoid its use. The China National Drug Administration (CNDA) has explicitly stated that sh-Oligopeptide-1 (EGF) should not be utilized as a cosmetic raw material due to its significant molecular weight impeding absorption and potential safety concerns on compromised skin barriers, classifying active EGF as a 'potent unauthorised drug' in cosmetic applications. EWG rates its allergy and immunotoxicity risk as low.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its theoretical promise as a cell-communicating peptide for skin regeneration, significant regulatory warnings regarding its efficacy due to poor skin absorption and unresolved questions about its fundamental bioactivity position SILKWORM SH-OLIGOPEPTIDE-1 as a questionable ingredient for topical cosmetic applications.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources